Literature DB >> 20200950

Time since prior fracture is a risk modifier for 10-year osteoporotic fractures.

Lora M Giangregorio1, William D Leslie.   

Abstract

The objective of this study was to assess the importance of time since prior fracture as a risk factor for future osteoporotic fractures and how it affects 10-year fracture rates. We identified 39,991 women 45 years of age or older undergoing baseline bone mineral density (BMD) testing (1990-2007) from a regional database that contains dual-energy X-ray absorptiometry (DXA) results for Manitoba, Canada. Health service records were used to identify nontrauma ICD-9-CM fracture codes preceding DXA, grouped as "major" fractures (n = 5178; hip, spine, forearm, and humerus) or "minor" fractures (n = 3479; ribs, sternum, pelvis, trunk, clavicle, scapula, patella, tibia/fibula, and ankle). Time since prior fracture was coded in years as less than 1, 1 to 5, 5 to 10, and more than 10. Incident fractures (ie, hip, spine, forearm, and humerus) after BMD testing were identified (mean follow-up 4.2 years, maximum 10 years) and studied in Cox proportional-hazards models adjusted for age, BMD T-score, and other covariates. After BMD testing, n = 1749 (4.4%) women experienced an incident fracture. Prior major fracture was a strong risk factor for incident fracture, greatest risk in the first year [hazard ratio (HR) 1.90, 95% confidence interval (CI) 1.60-2.25], declining by more than 10 years (HR 1.62, 95% CI 1.25-2.10). Prior minor fracture was a weaker risk factor, greatest in the first year (HR 1.45, 95% CI 1.13-1.87) and no longer significant by 1 to 5 years. Major and minor fractures both showed a time-dependent decline in importance as risk factors. In conclusion, time since prior fracture modifies future fracture risk, but prior fractures of the hip, spine, forearm, and humerus remain strong risk factors even 10 years later. Fracture risk assessment should emphasize the importance of prior fractures at these sites. (c) 2010 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Year:  2010        PMID: 20200950     DOI: 10.1002/jbmr.35

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  27 in total

1.  Screening: FRAX in clinical practice.

Authors:  Bo Abrahamsen
Journal:  Nat Rev Rheumatol       Date:  2011-10-04       Impact factor: 20.543

2.  FRAX: a coming of age.

Authors:  W D Leslie
Journal:  Osteoporos Int       Date:  2018-09-25       Impact factor: 4.507

3.  Ankle fractures do not predict osteoporotic fractures in women with or without diabetes.

Authors:  J M Pritchard; L M Giangregorio; G Ioannidis; A Papaioannou; J D Adachi; W D Leslie
Journal:  Osteoporos Int       Date:  2011-05-12       Impact factor: 4.507

4.  Characteristics of recurrent fractures.

Authors:  J A Kanis; H Johansson; A Odén; N C Harvey; V Gudnason; K M Sanders; G Sigurdsson; K Siggeirsdottir; L A Fitzpatrick; F Borgström; E V McCloskey
Journal:  Osteoporos Int       Date:  2018-06-12       Impact factor: 4.507

5.  Prior ankle fractures in postmenopausal women are associated with low areal bone mineral density and bone microstructure alterations.

Authors:  E Biver; C Durosier; T Chevalley; F R Herrmann; S Ferrari; R Rizzoli
Journal:  Osteoporos Int       Date:  2015-04-08       Impact factor: 4.507

6.  Economic impact and cost-effectiveness of fracture liaison services: a systematic review of the literature.

Authors:  C-H Wu; I-J Kao; W-C Hung; S-C Lin; H-C Liu; M-H Hsieh; S Bagga; M Achra; T-T Cheng; R-S Yang
Journal:  Osteoporos Int       Date:  2018-02-19       Impact factor: 4.507

7.  FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry.

Authors:  W D Leslie; S R Majumdar; S N Morin; L M Lix; H Johansson; A Oden; E V McCloskey; J A Kanis
Journal:  Osteoporos Int       Date:  2017-06-07       Impact factor: 4.507

8.  Evidence of sustained vertebral and nonvertebral antifracture efficacy with ibandronate therapy: a systematic review.

Authors:  Silvano Adami; Luca Idolazzi; Maurizio Rossini
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-04       Impact factor: 5.346

9.  A clinical decision rule to enhance targeted bone mineral density testing in healthy mid-life women.

Authors:  G Hawker; A Mendel; M A Lam; P S Akhavan; J Cancino-Romero; E Waugh; S Jamal; S Mian; S Jaglal
Journal:  Osteoporos Int       Date:  2011-12-10       Impact factor: 4.507

10.  Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.

Authors:  W D Leslie; L M Lix; L Langsetmo; C Berger; D Goltzman; D A Hanley; J D Adachi; H Johansson; A Oden; E McCloskey; J A Kanis
Journal:  Osteoporos Int       Date:  2010-12-16       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.